KCM
ADUS icon

Kennedy Capital Management’s Addus HomeCare ADUS Stock Holding History

Kennedy Capital Management’s Portfolio ADUS Stock Details ADUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5M Buy
263,955
+10,073
+4% +$951K 0.47% 44
2026
Q1 		$23.8M Buy
253,882
+35,541
+16% +$3.77M 0.5% 40
2025
Q4 		$23.4M Buy
218,341
+21,716
+11% +$2.49M 0.5% 42
2025
Q3 		$23.2M Buy
196,625
+17,824
+10% +$2M 0.51% 30
2025
Q2 		$20.6M Buy
178,801
+45,670
+34% +$4.93M 0.49% 37
2025
Q1 		$13.2M Buy
133,131
+51,898
+64% +$5.77M 0.31% 92
2024
Q4 		$10.2M Sell
81,233
-1,107
-1% -$140K 0.23% 136
2024
Q3 		$11M Sell
82,340
-6,040
-7% -$762K 0.24% 123
2024
Q2 		$10.3M Buy
88,380
+7,677
+10% +$822K 0.22% 151
2024
Q1 		$8.34M Sell
80,703
-24,352
-23% -$2.28M 0.17% 213
2023
Q4 		$9.75M Sell
105,055
-15,529
-13% -$1.35M 0.21% 168
2023
Q3 		$10.3M Sell
120,584
-32,364
-21% -$2.88M 0.25% 125
2023
Q2 		$14.2M Sell
152,948
-88,571
-37% -$8.45M 0.33% 79
2023
Q1 		$25.8M Sell
241,519
-27,719
-10% -$2.89M 0.76% 9
2022
Q4 		$26.8M Sell
269,238
-7,874
-3% -$823K 0.76% 8
2022
Q3 		$26.4M Sell
277,112
-1,889
-0.7% -$174K 0.78% 6
2022
Q2 		$23.2M Buy
279,001
+76,079
+37% +$6.38M 0.65% 15
2022
Q1 		$18.9M Sell
202,922
-18,153
-8% -$1.46M 0.45% 45
2021
Q4 		$20.7M Buy
221,075
+408
+0.2% +$36.7K 0.44% 46
2021
Q3 		$17.6M Sell
220,667
-7,004
-3% -$609K 0.39% 54
2021
Q2 		$19.9M Buy
227,671
+117,797
+107% +$11.5M 0.43% 41
2021
Q1 		$11.5M Buy
109,874
+49,419
+82% +$5.63M 0.23% 143
2020
Q4 		$7.08M Sell
60,455
-10,825
-15% -$1.12M 0.16% 239
2020
Q3 		$6.74M Buy
71,280
+424
+0.6% +$39.7K 0.19% 179
2020
Q2 		$6.56M Buy
70,856
+53,124
+300% +$4.59M 0.19% 178
2020
Q1 		$1.2M Buy
+17,732
New +$1.53M 0.04% 534
2018
Q2 		– Sell
-28,840
Closed -$1.4M – 727
2018
Q1 		$1.4M Buy
+28,840
New +$1.11M 0.03% 639
2014
Q2 		– Sell
-20,143
Closed -$464K – 743
2014
Q1 		$464K Buy
+20,143
New +$502K 0.01% 698

Other funds holding ADUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Kennedy Capital Management's ADUS Position: Q2 2026 in Review

Kennedy Capital Management increased its Addus HomeCare (ADUS) stake by 4% in Q2 2026, buying an estimated $951K and bringing the position to 263,955 shares worth $26.5M. The position accounts for 0.47% of the portfolio, ranked #44.

Kennedy Capital Management first reported a position in ADUS in Q1 2014 and has held it in 28 quarters since. The position peaked at $26.8M in Q4 2022. 302 funds tracked by Wall St. Rank hold ADUS as of Q2 2026.

  • Kennedy Capital Management held 263,955 shares of Addus HomeCare worth $26.5M as of Q2 2026.
  • Kennedy Capital Management bought 10,073 Addus HomeCare shares in Q2 2026, an estimated $951K.
  • Addus HomeCare made up 0.47% of Kennedy Capital Management's portfolio in Q2 2026, its #44 holding.
  • Kennedy Capital Management first reported a position in Addus HomeCare in Q1 2014 and has held it in 28 quarters since.
  • Kennedy Capital Management's Addus HomeCare position peaked at $26.8M in Q4 2022.
  • 302 funds tracked by Wall St. Rank held Addus HomeCare as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.